Tabimorelin
Withdrawn or never marketedMeasured in people, not heightBy mouthSmall molecule
An oral growth hormone releaser that most patients in its trial did not respond to, so it was abandoned.
An orally active ghrelin receptor agonist. In a phase 2 trial in 83 GH-deficient adults only 11% responded, and development stopped.
Risks. It blocks a liver enzyme that clears many other drugs, so it interferes with them.
On this page
- At the growth plate, members only
- Risks and side effects, members only
The rest of this page is for members
What has been measured, in whom, with every source, and what it does to the rest of you. And every article in the library.
Join for $11.99Lifetime · 3 of 10 founding spots left
Tax is added at checkout (VAT/GST where it applies).
Renews every month at the current price plus tax until you cancel. Cancel from your account before the next monthly charge to stop it.
Card purchases are sold and charged by Link (Stripe) under Link's terms and refund policy.
Already a member? Sign in
Educational content, not medical advice. Nothing here is a recommendation to take or stop taking anything — talk to a doctor about your own situation.